Skin Cancer/Melanoma

As Teddi Mellencamp reveals more about her cancer diagnosis and Shannen Doherty receives a standing ovation after her stage 4 cancer diagnosis, here’s what is happening in the oncology space this week.

Merkel cell carcinoma made headlines with the death of Jimmy Buffett. It’s rare and dangerous, and cases are becoming more common.

Tanning beds cause an increased risk of skin cancer among young people — especially those who have a family history of skin cancer.

As The Los Angeles Rams celebrate a cancer survivor and a 9/11 survivor reveals his fourth cancer diagnosis, this is what’s happening in the oncology space this week.

"Margaritaville" singer-songwriter Jimmy Buffett died four years after receiving a diagnosis of Merkel cell carcinoma that "can be really nasty," one expert tells CURE.

‘Margaritaville’ singer-songwriter Jimmy Buffett had received a diagnosis of skin cancer followed by lymphoma four years ago, according to TMZ.

It’s been a long road since being diagnosed with melanoma in early 2020.

The Hepzato Kit is a direct-to-liver therapy for patients with uveal melanoma with hepatic metastases.

Patients with advanced Merkel cell carcinoma treated with Opdivo had improved disease-free survival rates compared with those who underwent observation.

A recent study documented the benefits of maintaining normal vitamin D levels for patients with inoperable, locally advanced or metastatic melanoma receiving anti-PD-1 immunotherapy.

As Ben Alldis reveals previous cancer diagnosis and Luke Combs brings a Make-a-Wish cancer survivor on stage during a concert venue, this is what’s occurring in the oncology space this week.

A global trial recently launched that will investigate a personalized mRNA vaccine with Keytruda for patients with skin cancer.

A randomized clinical trial, CHEERS, determined that the combination of stereotactic body radiotherapy (SBRT) and immune checkpoint inhibitors (ICIs) were ineffective as treatment for patients with advanced solid tumors.

Treatment with a CAR-M cell therapy plus Keytruda is being assessed in a phase 1 study in patients with HER2-overexpressed tumors.

The TILVANCE-301trial, expected to be completed in 2030, is the latest study of what has been described as one of the “phenomenal discoveries in melanoma.”

After two years of follow-up, patients with advanced melanoma treated with Opdivo and Opdualag continued to obtain a survival benefit compared with Opdivo alone.

Here’s an overview of the new cancer regimens that gained Food and Drug Administration (FDA) approval in the spring of this year.

Marlana M. Orloff, MD, offers advice for patients who are diagnosed with metastatic uveal melanoma.

An expert on uveal melanoma reviews the treatment protocol for tebentafusp, which is approved for the treatment of metastatic disease.

Marlana M. Orloff, MD, discusses key efficacy data and reviews adverse events seen with tebentafusp in patients with metastatic uveal melanoma.

Dr Marlana M. Orloff provides an overview of the treatment landscape for metastatic uveal melanoma.

An expert on uveal melanoma discusses the presentation, diagnosis, and prognosis of the disease.

Marlana M. Orloff, MD, gives a brief overview of uveal melanoma, including its incidence and risk factors.

From Edward James Olmos and Khloé Karsashian both discussing their cancer diagnoses to a survivor making a movie musical about her diagnosis and more, here’s what’s happening in the oncology space this week.

May is National Melanoma and Skin Cancer Awareness Month, so we took a look at some of the top stories about the disease from 2023.